Geode Capital Management
VVOS icon

Geode Capital Management’s Vivos Therapeutics VVOS Stock Holding History

Geode Capital Management’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Sell
85,001
-10,542
-11% -$8.26K ﹤0.01% 4289
2026
Q1 		$113K Buy
95,543
+39,256
+70% +$62.9K ﹤0.01% 4104
2025
Q4 		$114K Buy
56,287
+2,998
+6% +$7.42K ﹤0.01% 4063
2025
Q3 		$165K Sell
53,289
-4,613
-8% -$20.9K ﹤0.01% 3988
2025
Q2 		$183K Buy
57,902
+553
+1% +$1.4K ﹤0.01% 3902
2025
Q1 		$163K Buy
57,349
+12,522
+28% +$49.2K ﹤0.01% 3903
2024
Q4 		$192K Buy
44,827
+16,025
+56% +$53.5K ﹤0.01% 3920
2024
Q3 		$75.2K Buy
28,802
+8,111
+39% +$21.2K ﹤0.01% 4171
2024
Q2 		$45.9K Buy
+20,691
New +$50.5K ﹤0.01% 4298
2023
Q4 		– Sell
-8,078
Closed -$38.8K – 4684
2023
Q3 		$38.8K Hold
8,078
– – ﹤0.01% 4480
2023
Q2 		$103K Hold
8,078
– – ﹤0.01% 4322
2023
Q1 		$68.9K Hold
8,078
– – ﹤0.01% 4446
2022
Q4 		$81K Sell
8,078
-18
-0.2% -$263 ﹤0.01% 4466
2022
Q3 		$131K Hold
8,096
– – ﹤0.01% 4433
2022
Q2 		$261K Buy
8,096
+26
+0.3% +$1.08K ﹤0.01% 4111
2022
Q1 		$540K Buy
8,070
+3,611
+81% +$236K ﹤0.01% 3896
2021
Q4 		$250K Buy
4,459
+1,505
+51% +$121K ﹤0.01% 4385
2021
Q3 		$298K Buy
2,954
+1,048
+55% +$110K ﹤0.01% 4273
2021
Q2 		$235K Buy
1,906
+1,411
+285% +$230K ﹤0.01% 4276
2021
Q1 		$82K Buy
+495
New +$88.4K ﹤0.01% 4335

Other funds holding VVOS

IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management's VVOS Position: Q2 2026 in Review

Geode Capital Management reduced its Vivos Therapeutics (VVOS) stake by 11% in Q2 2026, selling an estimated $8.26K and leaving 85,001 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4289.

Geode Capital Management first reported a position in VVOS in Q1 2021 and has held it in 20 quarters since. The position peaked at $540K in Q1 2022. 23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

  • Geode Capital Management held 85,001 shares of Vivos Therapeutics worth $38.6K as of Q2 2026.
  • Geode Capital Management sold 10,542 Vivos Therapeutics shares in Q2 2026, an estimated $8.26K.
  • Vivos Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4289 holding.
  • Geode Capital Management first reported a position in Vivos Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Vivos Therapeutics position peaked at $540K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.